This opportunity is no longer accepting applications.
grant RFA-AI-24-021

Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed)

This grant provides funding for projects that aim to create and use new models, tests, tools, or platforms to improve drug discovery for specific antibiotic-resistant bacteria, including carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa.

The purpose of this Notice of Funding Opportunity (NOFO) is to support milestone-driven projects focused on developing and utilizing novel predictive models, assays, tools, and/or platforms based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-neg…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $750,000
Award Amount: $750,000

Dates

Opportunity Released: April 1, 2024
Open for Submission: April 1, 2024
Submission Deadline: August 20, 2024
Application Window Closes: August 20, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.